Agios and Aurigene signs agreement to develop small molecule inhibitors for cancer metabolism target
Agios Pharmaceuticals and Aurigene Discovery Technologies announced that they have signed a global license agreement to research, develop and commercialize small molecule inhibitors of…
Read More...
Read More...